title: Histidine decarboxylase expression in pancreatic endocrine cells and related tumors.
abstract: Histidine decarboxylase (HDC) is an enzyme for decarboxylating l-histidine to histamine and is expressed in various types of cells including neuroendocrine tumors. Recent findings have demonstrated a high percentage of HDC immunoreactivity in many neuroendocrine tumors, including carcinoid tumors, small cell carcinomas of the lung, pheochromocytomas, and medullary carcinomas of the thyroid. HDC immunostaining was applied to pancreatic islet cells and related tumors to explore possible expression of HDC as a wide spectrum marker for neuroendocrine differentiation. A total of 24 cases (22 pancreatic endocrine neoplasms, one small cell carcinoma of the pancreas, and one mixed exocrine-endocrine carcinoma) along with normal pancreatic tissue were immunostained with the anti-HDC antibody. In a normal pancreas, a double immunostaining revealed possible colocalization of HDC with glucagon- or insulin-positive cells in the islets. Seventeen of 22 pancreatic endocrine neoplasms (77%) were found to be positive for HDC, and no distinct relation to hormonal activity was observed. One small cell carcinoma was strongly positive to HDC. One non-functional tumor with mixed exocrine and endocrine components showed a diffuse positive immunostaining for HDC, and some neoplastic glucagon- or somatostatin (SRIF)-positive cells coexpressed HDC. In conclusion, we demonstrated that the majority of pancreatic endocrine tumors expressed HDC, and we suggest that HDC is a wider new marker for neuroendocrine differentiation.
authors.affiliation: Department of Pathology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: Akihide
authors.initials: A
authors.lastname: Tanimoto
authors.forename: Yasumasa
authors.initials: Y
authors.lastname: Matsuki
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Tomita
authors.forename: Takakazu
authors.initials: T
authors.lastname: Sasaguri
authors.forename: Shohei
authors.initials: S
authors.lastname: Shimajiri
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Sasaguri
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006640:Histidine Decarboxylase / Q000378:metabolism*; D006801:Humans; D007124:Immunoenzyme Techniques; D007340:Insulinoma / Q000201:enzymology* / Q000473:pathology; D007515:Islets of Langerhans / Q000201:enzymology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000201:enzymology* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D006640:Histidine Decarboxylase